160 related articles for article (PubMed ID: 30539537)
21. Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter.
Li L; Zhang CL; Kang L; Wang RF; Yan P; Zhao Q; Yin L; Guo FQ
Cancer Biother Radiopharm; 2015 Oct; 30(8):342-8. PubMed ID: 26382009
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
23. Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector.
Takahashi M; Valdes G; Hiraoka K; Inagaki A; Kamijima S; Micewicz E; Gruber HE; Robbins JM; Jolly DJ; McBride WH; Iwamoto KS; Kasahara N
Cancer Gene Ther; 2014 Oct; 21(10):405-410. PubMed ID: 25301172
[TBL] [Abstract][Full Text] [Related]
24. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma.
Kaliberov SA; Market JM; Gillespie GY; Krendelchtchikova V; Della Manna D; Sellers JC; Kaliberova LN; Black ME; Buchsbaum DJ
Gene Ther; 2007 Jul; 14(14):1111-9. PubMed ID: 17495948
[TBL] [Abstract][Full Text] [Related]
25. Clinical trials with GDEPT: cytosine deaminase and 5-fluorocytosine.
Brown NL; Lemoine NR
Methods Mol Med; 2004; 90():451-7. PubMed ID: 14657578
[No Abstract] [Full Text] [Related]
26. Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model.
Graepler F; Lemken ML; Wybranietz WA; Schmidt U; Smirnow I; Gross CD; Spiegel M; Schenk A; Graf H; Lauer UA; Vonthein R; Gregor M; Armeanu S; Bitzer M; Lauer UM
World J Gastroenterol; 2005 Nov; 11(44):6910-9. PubMed ID: 16437592
[TBL] [Abstract][Full Text] [Related]
27. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
Pierrefite-Carle V; Baqué P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B
J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026
[TBL] [Abstract][Full Text] [Related]
28. [Effects of CD/5-FC suicide gene therapy system on human malignant glioma cells in vitro].
Lü SQ; Liu YS; Yang H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):174-6, 180. PubMed ID: 16145905
[TBL] [Abstract][Full Text] [Related]
29. Escherichia coli cytosine deaminase: Structural and biotechnological aspects.
Vosough P; Vafadar A; Naderi S; Alashti SK; Karimi S; Irajie C; Savardashtaki A; Taghizadeh S
Biotechnol Appl Biochem; 2024 Feb; 71(1):5-16. PubMed ID: 37743549
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma.
Kim JH; Kim JY; Kim SU; Cho KG
Biochem Biophys Res Commun; 2012 Jan; 417(1):534-40. PubMed ID: 22177952
[TBL] [Abstract][Full Text] [Related]
31. Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors.
Nakamura T; Sasaki T; Fujimori M; Yazawa K; Kano Y; Amano J; Taniguchi S
Biosci Biotechnol Biochem; 2002 Nov; 66(11):2362-6. PubMed ID: 12506973
[TBL] [Abstract][Full Text] [Related]
32. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
33. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.
Hamstra DA; Lee KC; Tychewicz JM; Schepkin VD; Moffat BA; Chen M; Dornfeld KJ; Lawrence TS; Chenevert TL; Ross BD; Gelovani JT; Rehemtulla A
Mol Ther; 2004 Nov; 10(5):916-28. PubMed ID: 15509509
[TBL] [Abstract][Full Text] [Related]
34. Subcutaneous or intrahepatic injection of suicide gene modified tumour cells induces a systemic antitumour response in a metastatic model of colon carcinoma in rats.
Pierrefite-Carle V; Baqué P; Gavelli A; Brossette N; Benchimol D; Bourgeon A; Saint Paul MC; Staccini P; Rossi B
Gut; 2002 Mar; 50(3):387-91. PubMed ID: 11839720
[TBL] [Abstract][Full Text] [Related]
35. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.
Stolworthy TS; Korkegian AM; Willmon CL; Ardiani A; Cundiff J; Stoddard BL; Black ME
J Mol Biol; 2008 Mar; 377(3):854-69. PubMed ID: 18291415
[TBL] [Abstract][Full Text] [Related]
36. Photochemical internalization-mediated nonviral gene transfection: polyamine core-shell nanoparticles as gene carrier.
Zamora G; Wang F; Sun CH; Trinidad A; Kwon YJ; Cho SK; Berg K; Madsen SJ; Hirschberg H
J Biomed Opt; 2014; 19(10):105009. PubMed ID: 25341069
[TBL] [Abstract][Full Text] [Related]
37. Implication of functional activity for determining therapeutic efficacy of suicide genes in vitro.
Gopinath P; Ghosh SS
Biotechnol Lett; 2008 Nov; 30(11):1913-21. PubMed ID: 18594769
[TBL] [Abstract][Full Text] [Related]
38. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
[TBL] [Abstract][Full Text] [Related]
39. Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
Chung T; Na J; Kim YI; Chang DY; Kim YI; Kim H; Moon HE; Kang KW; Lee DS; Chung JK; Kim SS; Suh-Kim H; Paek SH; Youn H
Theranostics; 2016; 6(10):1477-90. PubMed ID: 27446484
[TBL] [Abstract][Full Text] [Related]
40. [Antitumor activity of the recombinant rClone30-CD/5-FC system].
Lu Z; Zhang TY; Han MM; Bai FL; Wu W; Tian GY; Ren GP; Li DS
Yao Xue Xue Bao; 2013 Feb; 48(2):261-8. PubMed ID: 23672024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
